ONiP Logo
NLFC Logo
EONS Logo

Lung Cancer

Background
The clinical management of lung cancer is a constantly evolving topic. It can be challenging for busy nurses to keep up to date with rapidly changing guidelines and new evidence around best practice and effective clinical management. Here, you can access modules to support your daily work that will help you give your patients the best quality care. Please see our disclaimer regarding module content.

Duration
Each foundation and advanced e-learning module will take you just 60 minutes of module-based learning. Pre-reading will take approximately 30-60 minutes. You can find pre-reading materials for each module in the ‘resources’ section beside the modules. Saving where you left off, you can dip in and out of the modules whenever you have the time. You are encouraged to take notes/save personal screenshots during the module to reinforce your learning.

Accreditation 
Our lung cancer modules are accredited by the Federation of the Royal College of Nursing (RCN). The RCN cannot confirm the competence of any practitioner. You will receive a certificate via email for 1 hour of learning per module upon completion.

 

Immunotherapy is a fundamentally different approach to cancer treatment which has unique implications for oncology nurses in their day-to-day clinical practice.


CPD Module

Immunotherapy foundation and advanced modules have been developed to provide oncology nurses with timely knowledge about the role of immunotherapy in non-small cell lung cancer (NSCLC) and to empower nurses with the skills to understand and manage these unique considerations in their clinical practice.

under update

Immunotherapy for Non-Small Cell Lung Cancer: Foundation Module

Foundation
under update

Immunotherapy for Non-Small Cell Lung Cancer: Advanced Module

Advanced

* Save your place and obtain CME credits.

† Your place will not be saved.


Review


The faculty

Josie Roberts

Lung Cancer Nurse Specialist The Rotherham NHS Foundation Trust

Rachel Thomas

Mesothelioma and Lung Cancer Clinical Specialist Guy’s and St Thomas’ NHS Trust

Resources

Foundation


Advanced

Biomarkers have become increasingly more important in oncology, providing valuable information on disease diagnosis and prognosis as well as guiding the selection of specific therapy for patients.


CPD Module

The emerging role of Biomarkers in Lung Cancer foundation and advanced modules have been developed to provide nurses with an understanding of the evolving role of biomarkers in non-small cell lung cancer (NSCLC) and their implications for clinical treatment.

under update

Biomarkers and their Emerging Role in Lung Cancer: Foundation Module

Foundation
under update

Biomarkers and their Emerging Role in Lung Cancer: Advanced Module

Advanced

* Save your place and obtain CME credits.

† Your place will not be saved.


Review


The faculty

Jackie Fenemore

Lung Cancer Advanced Nurse Practitioner Christie Hospital Foundation Trust

Sandra Wakelin

Macmillan Lung Cancer Clinical Nurse Specialist Maidstone Hospital, Kent Oncology Centre

Resources

Foundation


Advanced

 

 

These independent educational activities have been developed in collaboration with the National Lung Cancer Forum for Nurses and is supported by educational grants provided by Astra Zeneca Pharmaceuticals. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this programme. The activity is run independently of the financial supporter and all content is created by the faculty. No funder has had input into the content of the activity.